ADDENDUM TO THE SECOND AMENDED AND RESTATED LICENSE, PRODUCT DEVELOPMENT AND SUPPLY UMBRELLA AGREEMENTAddendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement • November 8th, 2024 • TELA Bio, Inc. • Surgical & medical instruments & apparatus
This Addendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement (this “Addendum”), is made as of the 1st day of August, 2024, by and between TELA Bio, Inc. (“TELA Bio”), and Aroa Biosurgery Limited (“Aroa”), and sets out the terms of TELA Bio's and Aroa's agreement with respect to certain terms applicable to the LPR, PRS and IHR Product lines (as defined below in this Addendum).
ADDENDUM TO THE SECOND AMENDED AND RESTATED LICENSE, PRODUCT DEVELOPMENT AND SUPPLY UMBRELLA AGREEMENTAddendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement • March 30th, 2020 • TELA Bio, Inc. • Surgical & medical instruments & apparatus
This addendum to the Umbrella Agreement (“Addendum”), is made as of the 27th day of August, 2019, and sets out the terms of the parties’ agreements with respect to the OviTex LPR Low Profile Robotic Product (“LPR Product”).
ADDENDUM TO THE SECOND AMENDED AND RESTATED LICENSE, PRODUCT DEVELOPMENT AND SUPPLY UMBRELLA AGREEMENTAddendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement • March 22nd, 2024 • TELA Bio, Inc. • Surgical & medical instruments & apparatus
This Addendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement (this “Addendum”), is made as of the 13 day of August, 2020, by and between TELA Bio, Inc. (“TELA Bio”), and Aroa Biosurgery Limited (“Aroa”), and sets out the terms of TELA Bio's and Aroa's agreement with respect to pricing of/for the ENDOFORM® PRS PLGA Reconstructive Template (“PRS PLGA Product”).
ADDENDUM TO THE SECOND AMENDED AND RESTATED LICENSE, PRODUCT DEVELOPMENT AND SUPPLY UMBRELLA AGREEMENTAddendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement • May 15th, 2020 • TELA Bio, Inc. • Surgical & medical instruments & apparatus
This Addendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement (this “Addendum”) is made as of the 15th day of February, 2020, by and between TELA Bio, Inc. (“TELA Bio”), and Aroa Biosurgery Limited (“Aroa”), and sets out the terms of TELA Bio’s and Aroa’s agreements with respect to the assignment, transfer and conveyance from Aroa to TELA Bio of the FDA 510(k) clearances (K183398) for the Endoform® Restella Reconstructive Template (the “Restella Product”) as more particularly described in Exhibit B attached hereto (the “Restella Product Clearance”).
